Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Slevin

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Cancer|January 1, 1991
The clinical pharmacology of etoposideM L Slevin
British Journal of Hospital Medicine|July 1, 1987
Talking about cancer: how much is too much?M L Slevin
BMJ (Clinical Research Ed.)|February 17, 1996
Adjuvant treatment for colorectal cancerM L Slevin
BMJ (Clinical Research Ed.)|August 22, 1992
Quality of life: philosophical question or clinical reality?M L Slevin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Low-dose oral etoposide: a new role for an old drug?M L Slevin
The Lancet. Oncology|March 22, 2002
Alternative cancer curesD Farrugia, M L Slevin
Lancet (London, England)|May 6, 1989
Pamidronate to reduce bone pain in normocalcaemic patient with disseminated prostatic carcinomaT Masud, M L Slevin
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1992
Ambulatory chemotherapyM T Seymour, M L Slevin
Respiratory Medicine|September 1, 1989
Small cell lung cancer: single agents revisitedP I Clark, M L Slevin
British Journal of Cancer|March 1, 1991
Medroxyprogesterone acetate (MPA) in advanced granulosa cell tumours of the ovary--a new therapeutic approach?S T Malik, M L Slevin
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Cancer|January 1, 1991
The clinical pharmacology of etoposideM L Slevin
British Journal of Hospital Medicine|July 1, 1987
Talking about cancer: how much is too much?M L Slevin
BMJ (Clinical Research Ed.)|February 17, 1996
Adjuvant treatment for colorectal cancerM L Slevin
BMJ (Clinical Research Ed.)|August 22, 1992
Quality of life: philosophical question or clinical reality?M L Slevin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Low-dose oral etoposide: a new role for an old drug?M L Slevin
The Lancet. Oncology|March 22, 2002
Alternative cancer curesD Farrugia, M L Slevin
Lancet (London, England)|May 6, 1989
Pamidronate to reduce bone pain in normocalcaemic patient with disseminated prostatic carcinomaT Masud, M L Slevin
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1992
Ambulatory chemotherapyM T Seymour, M L Slevin
Respiratory Medicine|September 1, 1989
Small cell lung cancer: single agents revisitedP I Clark, M L Slevin
British Journal of Cancer|March 1, 1991
Medroxyprogesterone acetate (MPA) in advanced granulosa cell tumours of the ovary--a new therapeutic approach?S T Malik, M L Slevin
Pageof 14